Obsidio (Acquired)

Obsidio (Acquired) has been recognized as an Innovation Leader at LSI's Emerging Medtech Summit 2020.

Ehsan

Ehsan Jabbarzadeh

Founder & CEO

Obsidio (Acquired)

Biomaterial platform for minimally-invasive occlusion of blood vessels

Share

Upcoming LSI Events

Trusted By The Companies Pioneering What’s Next

  • 0-Minnetronix.png
  • 1-jnj.png
  • 2-medtronic.png
  • 3-abbott.png
  • 4-baxter.png
  • 5-mckinsey.png
  • 7-bostonscientific.png
  • 8-bd.png
  • 9-smithnephew.png
  • 10-stryker.png
  • 33m.png
  • allergan.png
  • bbraun.png
  • beckmancoulter.png
  • cardinal.png
  • depuysynthes.png
  • drager.png
  • edwardslifesciences.png
  • ethicon.png
  • ge.png
  • gore.png
  • health-advances.png
  • hospira.png
  • jlabs.png
  • kimberlyclark.png
  • merck.png
  • olympus.png
  • orthofix.png
  • philips.png
  • sanofigenzyme.png
  • tecan.png
  • teleflex.png
  • terumo.png
  • zimmerbiomet.png